IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,083,000 | -34.3% | 261,382 | -43.8% | 0.00% | -60.0% |
| Q4 2017 | $7,738,000 | +37.1% | 464,831 | +67.1% | 0.01% | +25.0% |
| Q3 2017 | $5,646,000 | -75.7% | 278,196 | -80.8% | 0.00% | -76.5% |
| Q2 2017 | $23,279,000 | +91.0% | 1,445,977 | +50.1% | 0.02% | +88.9% |
| Q1 2017 | $12,189,000 | +62.1% | 963,655 | +69.8% | 0.01% | +50.0% |
| Q4 2016 | $7,519,000 | -38.3% | 567,595 | +10.4% | 0.01% | -33.3% |
| Q3 2016 | $12,187,000 | -26.7% | 514,292 | -10.8% | 0.01% | -25.0% |
| Q2 2016 | $16,616,000 | +111.1% | 576,650 | +134.5% | 0.01% | +100.0% |
| Q1 2016 | $7,872,000 | -75.1% | 245,922 | -66.8% | 0.01% | -72.7% |
| Q4 2015 | $31,645,000 | +170.5% | 740,129 | +122.8% | 0.02% | +144.4% |
| Q3 2015 | $11,697,000 | +4.9% | 332,262 | +36.9% | 0.01% | +28.6% |
| Q2 2015 | $11,147,000 | +13.0% | 242,770 | +15.3% | 0.01% | +16.7% |
| Q1 2015 | $9,863,000 | +28.3% | 210,483 | -13.3% | 0.01% | +20.0% |
| Q4 2014 | $7,687,000 | +97.9% | 242,682 | +48.0% | 0.01% | +150.0% |
| Q3 2014 | $3,885,000 | -9.4% | 163,950 | +14.7% | 0.00% | -33.3% |
| Q2 2014 | $4,286,000 | -19.7% | 142,986 | -29.3% | 0.00% | -25.0% |
| Q1 2014 | $5,339,000 | -34.5% | 202,169 | -37.7% | 0.00% | -33.3% |
| Q4 2013 | $8,153,000 | +3.4% | 324,347 | -15.8% | 0.01% | 0.0% |
| Q3 2013 | $7,885,000 | – | 385,269 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |